Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up
Status:
Completed
Trial end date:
2019-11-08
Target enrollment:
Participant gender:
Summary
The Primary Objective of this study is to compare the effectiveness of HIV clinic-based
extended-release Naltrexone (XR-NTX) in decreasing substance use and increasing HIV viral
suppression in HIV-infected participants with opioid use disorder to Treatment as Usual in
this population.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Oregon Health and Science University
Collaborators:
Jackson Health System Johns Hopkins University National Institute on Drug Abuse (NIDA) Ruth M. Rothstein CORE Center Sunshine Care Clinic Tarzana Treatment Center Tarzana Treatment Centers University of Kentucky Whitman-Walker Health